Wikidata

(Q113939399)

English

Research Study to Look at How Well Semaglutide Works in People Living With Heart Failure, Obesity and Type 2 Diabetes

clinical trial

In more languages
default for all languages
No label defined

No description defined

Statements

short name
STEP HFpEF DM (English)
0 references
title
Effect of Semaglutide 2.4 mg Once-weekly on Function and Symptoms in Subjects With Obesity-related Heart Failure With Preserved Ejection Fraction, and Type 2 Diabetes (English)
0 references
country
Argentina
0 references
Austria
0 references
Canada
0 references
Germany
0 references
Hungary
0 references
India
0 references
Israel
0 references
Italy
0 references
Japan
0 references
Netherlands
0 references
Poland
0 references
Spain
0 references
United Kingdom
0 references
start time
15 June 2021
0 references
end time
27 June 2023
0 references
number of participants
610
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q113939399&oldid=2148959978"